ALK2 plays an important role in the expression of hepcidin due to inflammatory cytokines and recent studies have focused on pharmacologically inhibiting this pathway.[25, 26] Future assessment of these alternative erythropoietic pathways may provide a more complete understanding of both anemia of chronic disease and anemia of unknown etiology. Here, ACVR1 is linked to anemia (phenotype).